Changchun GeneScience Pharmaceutical Co., Ltd. – FDA Inspection, Apr 24, 2026

Record Details

This FDA Inspection record concerns Changchun GeneScience Pharmaceutical Co., Ltd., with an inspection on April 24, 2026, issued by the Office of Inspections and Investigations, covering human drugs.

Company: Changchun GeneScience Pharmaceutical Co., Ltd.
Inspection Date: April 24, 2026
Product Type: Human Drugs
Office: Office of Inspections and Investigations
Person: Joseph A. Piechocki (Issuing Officer)

View Company Profile

ID · 6e4c5b4d-7d84-4d7f-9791-b6cfa4e79a42

Inspection Facts

Inspection number: 1316458
FDA center: Human Drugs
Outcome: Form 483 issued

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Changchun GeneScience Pharmaceutical Co., Ltd.

FDA Inspection

Changchun GeneScience Pharmaceutical Co., Ltd.April 24, 2026

Changchun GeneScience Pharmaceutical Co., Ltd. – FDA Inspection, Apr 24, 2026

Record Details

This FDA Inspection record concerns Changchun GeneScience Pharmaceutical Co., Ltd., with an inspection on April 24, 2026, issued by the Office of Inspections and Investigations, covering human drugs.